| Market Cap | 876.44M | P/E | 7.69 | EPS this Y | -23.30% | Ern Qtrly Grth | -68.70% |
| Income | 113.03M | Forward P/E | 6.95 | EPS next Y | 13.00% | 50D Avg Chg | -14.00% |
| Sales | 2.35B | PEG | 0.65 | EPS past 5Y | -1.07% | 200D Avg Chg | -25.00% |
| Dividend | 23.00% | Price/Book | 0.94 | EPS next 5Y | 15.00% | 52W High Chg | -58.00% |
| Recommedations | 2.00 | Quick Ratio | 1.59 | Shares Outst. | 121.32M | 52W Low Chg | 8.00% |
| Insider Own | 3.38% | ROA | 3.47% | Shares Float | 115.25M | Beta | 0.91 |
| Inst Own | 66.21% | ROE | 11.83% | Short Shares | 0 | Price | 7.23 |
| Gross Margin | 24.33% | Profit Margin | 4.81% | Avg. Volume | 4,433,078 | Target Price | 15.00 |
| Oper. Margin | 10.37% | Earnings | Apr 28 | Volume | 5,756,645 | Change | -7.01% |
The GEO Group (NYSE: GEO) is the first fully integrated equity real estate investment trust specializing in the design, financing, development, and operation of secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO is a leading provider of enhanced in-custody rehabilitation, post-release support, electronic monitoring, and community-based programs. GEO's worldwide operations include the ownership and/or management of 125 facilities totaling approximately 93,000 beds, including projects under development, with a workforce of approximately 23,000 professionals.
